Autism spectrum disorder (ASD) is a severe
neurodevelopmental disorder characterized by social deficits and repetitive,
stereotyped behaviors. In recent years, its global prevalence has continued to
rise, but its pathogenesis remains unclear. Neuroinflammation and mitochondrial
dysfunction are considered two key components in the pathological process of
ASD, and a vicious cycle may exist between them. However, whether this cycle is
driven by the P2X7R/NLRP3 signaling pathway and what specific role it plays in
the development of ASD behavioral phenotypes remain to be systematically validated.
In this study, a sodium valproate-induced ASD mouse model was used, and the
mice were randomly divided into a control group, a model group, and an
intervention group treated with the P2X7R-selective antagonist A-438079. Social
skills, novelty preferences, and stereotyped behaviors were assessed using the
three-box social test, bead embedding test, and self-grooming test. The
expression levels of P2X7R, NLRP3, ASC, and inflammatory factors IL-1β and
IL-18 in the prefrontal cortex were detected by Western blot and ELISA. Mitochondrial
ultrastructure was observed using transmission electron microscopy, and the ATP
levels and reactive oxygen species (ROS) levels were measured. The results
showed that the model group mice exhibited significant social impairment, loss
of novelty preference, and increased stereotyped behaviors (P<0.01). The expression of
P2X7R/NLRP3 pathway-related proteins and inflammatory factors in the prefrontal
cortex was significantly upregulated, mitochondrial structure was damaged, ATP
content decreased, and ROS levels increased (P<0.01). However, after A-438079 intervention, these behavioral
deficits were significantly improved, inflammatory responses were reduced,
mitochondrial structure was repaired, energy metabolism function was restored,
and ROS production decreased (P<0.05).
This indicates that abnormal activation of the P2X7R/NLRP3 pathway participates
in the occurrence and development of core behavioral deficits in ASD by
exacerbating neuroinflammation and impairing mitochondrial function. Inhibition
of P2X7R may effectively break the vicious cycle of “inflammation-mitochondrial
damage,” suggesting that this receptor may exert its regulatory role through
NLRP3 inflammasome-dependent and potentially independent pathways, and is a
potential key target connecting neuroimmunity and energy metabolism. This study
provides new experimental evidence for the study of the mechanisms of ASD and
the development of intervention strategies.
Xiangqian Wei, Tuo Li, Lijia Cao, Lixian Guo, Wenling Li
. Effects of the
P2X7R/NLRP3 pathway on behavior and neural mitochondrial function in mice with
autism spectrum disorder[J]. Hereditas(Beijing), 0
: 0
.
DOI: 10.16288/j.yczz.26-149